Literature DB >> 19052773

Role of the Wilms' tumour transcription factor, Wt1, in blood vessel formation.

Holger Scholz1, Kay-Dietrich Wagner, Nicole Wagner.   

Abstract

Blood vessel formation is important for normal organ development and tumour growth. A highly specialised developmental program of vessel formation exists in the heart and is essential for normal cardiogenesis. From mouse models, it became clear that the Wilms' tumour protein Wt1 is required for normal heart development. Originally identified as a tumour suppressor gene based on its mutational inactivation in Wilms' tumour or nephroblastoma, Wt1 is nowadays recognised to have much broader functions in organogenesis and pathophysiology. The multiple tasks of Wt1 are not only limited to the kidney but involve the heart and vascular system as well. In this review, we focus on recent findings about the importance of Wt1 in heart and coronary vessel development and the identified molecular mechanisms. In addition, we discuss the implication of Wt1 in the vascular response to myocardial ischaemia and its oncogenic potential as a promoter of tumour angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052773     DOI: 10.1007/s00424-008-0621-3

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  89 in total

Review 1.  Molecular interactions between neurotrophin receptors.

Authors:  G Dechant
Journal:  Cell Tissue Res       Date:  2001-08       Impact factor: 5.249

Review 2.  Transcriptional regulation by WT1 in development.

Authors:  Stefan G E Roberts
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

3.  The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo.

Authors:  N Wagner; J F Michiels; A Schedl; K-D Wagner
Journal:  Oncogene       Date:  2008-01-21       Impact factor: 9.867

4.  GATA4 transcription factor is required for ventral morphogenesis and heart tube formation.

Authors:  C T Kuo; E E Morrisey; R Anandappa; K Sigrist; M M Lu; M S Parmacek; C Soudais; J M Leiden
Journal:  Genes Dev       Date:  1997-04-15       Impact factor: 11.361

5.  Origin and development of the epicardium in the mouse embryo.

Authors:  M Komiyama; K Ito; Y Shimada
Journal:  Anat Embryol (Berl)       Date:  1987

6.  The Wilms' tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction.

Authors:  Kay-Dietrich Wagner; Nicole Wagner; Anja Bondke; Benno Nafz; Bert Flemming; Heinz Theres; Holger Scholz
Journal:  FASEB J       Date:  2002-05-08       Impact factor: 5.191

7.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

8.  SUMO-1 modification of the Wilms' tumor suppressor WT1.

Authors:  Gromoslaw A Smolen; Maria T Vassileva; Julie Wells; Michael J Matunis; Daniel A Haber
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

9.  Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease.

Authors:  Ryuichi Morishita; Motokuni Aoki; Naotaka Hashiya; Hirofumi Makino; Keita Yamasaki; Junya Azuma; Yoshiki Sawa; Hikaru Matsuda; Yasufumi Kaneda; Toshio Ogihara
Journal:  Hypertension       Date:  2004-07-06       Impact factor: 10.190

Review 10.  The many facets of the Wilms' tumour gene, WT1.

Authors:  Peter Hohenstein; Nicholas D Hastie
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

View more
  6 in total

1.  Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development.

Authors:  Sunny Hartwig; Jacqueline Ho; Priyanka Pandey; Kenzie Macisaac; Mary Taglienti; Michael Xiang; Gil Alterovitz; Marco Ramoni; Ernest Fraenkel; Jordan A Kreidberg
Journal:  Development       Date:  2010-04       Impact factor: 6.868

2.  A lacZ reporter gene expression atlas for 313 adult KOMP mutant mouse lines.

Authors:  David B West; Ravi K Pasumarthi; Brian Baridon; Esi Djan; Amanda Trainor; Stephen M Griffey; Eric K Engelhard; Jared Rapp; Bowen Li; Pieter J de Jong; K C Kent Lloyd
Journal:  Genome Res       Date:  2015-01-15       Impact factor: 9.043

Review 3.  WT1: The Hinge Between Anemia Correction and Cancer Development in Chronic Kidney Disease.

Authors:  Wen-Chin Lee; Chien-Hua Chiu; Tian-Huei Chu; Yu-Shu Chien
Journal:  Front Cell Dev Biol       Date:  2022-04-06

4.  Gata4 and Sp1 regulate expression of the erythropoietin receptor in cardiomyocytes.

Authors:  Sandy von Salisch; Martin Klar; Boris Thurisch; Jörg Bungert; Christof Dame
Journal:  J Cell Mol Med       Date:  2011-09       Impact factor: 5.310

5.  Injury-induced fetal reprogramming imparts multipotency and reparative properties to pericardial adipose stem cells.

Authors:  Jianfeng Tang; Xiaoming Wang; Kezhe Tan; Hongtao Zhu; Youming Zhang; Weili Ouyang; Xueqing Liu; Zhaoping Ding
Journal:  Stem Cell Res Ther       Date:  2018-08-13       Impact factor: 6.832

6.  Transcriptional Regulation of HMOX1 Gene in Hezuo Tibetan Pigs: Roles of WT1, Sp1, and C/EBPα.

Authors:  Wei Wang; Qiaoli Yang; Kaihui Xie; Pengfei Wang; Ruirui Luo; Zunqiang Yan; Xiaoli Gao; Bo Zhang; Xiaoyu Huang; Shuangbao Gun
Journal:  Genes (Basel)       Date:  2020-03-26       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.